MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

47.44 -4.15 (-8.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,084,126
Open 50.77
Bid (Size) 47.05 (1,100)
Ask (Size) 47.12 (1,000)
Prev. Close 51.59
Today's Range 46.38 - 51.53
52wk Range 22.28 - 59.55
Shares Outstanding 394,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 ETFs For the Coming Genomics Revolution ↗
Genomics companies are an exciting frontier in health care, and ETFs can help to diversify to control risk while positioning investors to benefit. 
Via MarketBeat
Topics ETFs
News headline image
Why Is Moderna (MRNA) Stock Rocketing Higher Today
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 5.1% in the afternoon session after the stock's positive momentum was extended as... 
Via StockStory

Performance

YTD
+53.7%
+53.7%
1 Month
-2.3%
-2.3%
3 Month
-14.9%
-14.9%
6 Month
+69.6%
+69.6%
1 Year
+72.8%
+72.8%

More News

Read More
Wednesday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
Via Investor Brand Network
Curious about which S&P500 stocks are generating unusual volume on Monday? Find out below. ↗
Via Chartmill
NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Advanced Drug Delivery and Platform-Based Biotech Innovation
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
From BioMedWire
Via GlobeNewswire
News headline image
Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026 ↗
Via The Motley Fool
News headline image
Moderna to Present at Upcoming Conference in June 2026
Via ACCESS Newswire
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
News headline image
Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting
Via ACCESS Newswire
News headline image
Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus
Via ACCESS Newswire
News headline image
Anterix Stock Is Up 140%. Here's Why One Investor Just Bought $15.8 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Cash-Burning Stocks with Open Questions
Via StockStory
Topics Bankruptcy
News headline image
2 Healthcare Stocks Worth Investigating and 1 Facing Headwinds
Via StockStory
Stay informed with the top movers within the S&P500 index on Tuesday. ↗
Via Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally ↗
Via The Motley Fool
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Gapping S&P500 stocks in Wednesday's session ↗
Via Chartmill
News headline image
Moderna Recognized by TIME as One of the World's Most Impactful Companies
Via ACCESS Newswire
News headline image
Stock Market Today, May 11: Chipmakers Drive Midday Gains Despite Oil Concerns ↗
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
Biotech Stocks Rally on Hantavirus Fears: Is the Surge Overdone? ↗
Via The Motley Fool
Topics Death
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
Via Investor Brand Network

Frequently Asked Questions

Is Moderna, Inc. - Common Stock publicly traded?
Yes, Moderna, Inc. - Common Stock is publicly traded.
What exchange does Moderna, Inc. - Common Stock trade on?
Moderna, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Moderna, Inc. - Common Stock?
The ticker symbol for Moderna, Inc. - Common Stock is MRNA on the Nasdaq Stock Market
What is the current price of Moderna, Inc. - Common Stock?
The current price of Moderna, Inc. - Common Stock is 47.44
When was Moderna, Inc. - Common Stock last traded?
The last trade of Moderna, Inc. - Common Stock was at 06/05/26 04:00 PM ET
What is the market capitalization of Moderna, Inc. - Common Stock?
The market capitalization of Moderna, Inc. - Common Stock is 18.69B
How many shares of Moderna, Inc. - Common Stock are outstanding?
Moderna, Inc. - Common Stock has 19B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story